Comparison of the pharmacokinetics, safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulation

BACKGROUND: Somatropin is recombinant human growth hormone (GH) used for the treatment of growth failure in children and GH deficiency in adults. Two concentrations of a liquid formulation have been developed: 5.83 and 8.0 mg/mL. This trial compared the pharmacokinetics (PK), safety and tolerability...

Descripción completa

Detalles Bibliográficos
Autores principales: Liedert, Bernd, Forssmann, Ulf, Wolna, Peter, Golob, Michaela, Kovar, Andreas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987775/
https://www.ncbi.nlm.nih.gov/pubmed/20961422
http://dx.doi.org/10.1186/1472-6904-10-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987775/
https://www.ncbi.nlm.nih.gov/pubmed/20961422
http://dx.doi.org/10.1186/1472-6904-10-14

Ejemplares similares